Author: Katherine Drabiak, J.D.

Uncategorized

As Genetic Testing for Breast Cancer Gene Mutation Expands, Questions Arise About Treatment Decisions

FDA Regulation Genetic Test Genomics Health Law Regulation of Emerging Technology

Laboratory Developed Tests Under Scrutiny: FDA Questions Validity and Utility of Oncotype Dx and Prolaris Tests for Personalized Cancer Treatment